1,660
Views
13
CrossRef citations to date
0
Altmetric
Review

GUCY2C ligand replacement to prevent colorectal cancer

, &
Pages 713-718 | Accepted 11 Apr 2016, Published online: 17 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Madison M. Crutcher, Trevor R. Baybutt, Jessica S. Kopenhaver, Adam E. Snook & Scott A. Waldman. (2022) Emerging drug targets for colon cancer: A preclinical assessment. Expert Opinion on Therapeutic Targets 26:3, pages 207-216.
Read now
Amanda N. Lisby, John C. Flickinger$suffix/text()$suffix/text(), Babar Bashir, Megan Weindorfer, Sanjna Shelukar, Madison Crutcher, Adam E. Snook & Scott A. Waldman. (2021) GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer. Expert Review of Precision Medicine and Drug Development 6:2, pages 117-129.
Read now

Articles from other publishers (11)

Matthew D. Di Guglielmo, Jennifer Holbrook, Deborah Stabley, Katherine M. Robbins, Bobbie Boyce, Heather Hardy & Adebowale Adeyemi. (2023) The Intestinal Tract Brush Border in Young Children Uniformly Expresses Guanylate Cyclase C. Applied Immunohistochemistry & Molecular Morphology 31:3, pages 154-162.
Crossref
Daniel Stehle, Mariagiovanna Barresi, Jennifer Schulz & Robert Feil. (2023) Heterogeneity of cGMP signalling in tumour cells and the tumour microenvironment: Challenges and chances for cancer pharmacology and therapeutics. Pharmacology & Therapeutics 242, pages 108337.
Crossref
Claudia Ceci, Pedro Miguel Lacal & Grazia Graziani. (2022) Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential. Pharmacology & Therapeutics 236, pages 108106.
Crossref
Belén L. Bouzo, Saínza Lores, Raneem Jatal, Sandra Alijas, María José Alonso, Inmaculada Conejos-Sánchez & María de la Fuente. (2021) Sphingomyelin nanosystems loaded with uroguanylin and etoposide for treating metastatic colorectal cancer. Scientific Reports 11:1.
Crossref
John C FlickingerJrJr, Jeffrey A Rappaport, Joshua R Barton, Trevor R Baybutt, Amanda M Pattison, Adam E Snook & Scott A Waldman. (2021) Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies. Biomarkers in Medicine.
Crossref
Katia Cappelli, Rodolfo Gialletti, Beniamino Tesei, Gabrio Bassotti, Katia Fettucciari, Stefano Capomaccio, Laura Bonfili, Massimiliano Cuccioloni, Anna Maria Eleuteri, Andrea Spaterna & Fulvio Laus. (2019) Guanylin, Uroguanylin and Guanylate Cyclase-C Are Expressed in the Gastrointestinal Tract of Horses. Frontiers in Physiology 10.
Crossref
Ankita Mehta & Bhoomika M. Patel. (2019) Therapeutic opportunities in colon cancer: Focus on phosphodiesterase inhibitors. Life Sciences 230, pages 150-161.
Crossref
Scott A Waldman & Michael Camilleri. (2018) Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders. Gut 67:8, pages 1543-1552.
Crossref
Matthew D. Di Guglielmo, Dalal Tonb, Zhaoping He, Adebowale Adeyemi & Kenneth L. van Golen. (2018) Pilot Study Measuring the Novel Satiety Hormone, Pro-Uroguanylin, in Adolescents With and Without Obesity. Journal of Pediatric Gastroenterology & Nutrition 66:3, pages 489-495.
Crossref
Peng Li, Jieru Lin, Adam Snook & Scott Waldman. (2017) ST-Producing E. coli Oppose Carcinogen-Induced Colorectal Tumorigenesis in Mice. Toxins 9:9, pages 279.
Crossref
Amanda M. Pattison, Erik S. Blomain, Dante J. Merlino, Fang Wang, Mary Ann S. Crissey, Crystal L. Kraft, Jeff A. Rappaport, Adam E. Snook, John P. Lynch & Scott A. Waldman. (2016) Intestinal Enteroids Model Guanylate Cyclase C-Dependent Secretion Induced by Heat-Stable Enterotoxins. Infection and Immunity 84:10, pages 3083-3091.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.